Sjögren's disease
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Ask Patient
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
Sjögren's disease is a disorder whose main features are dry eyes and a dry mouth. The condition typically develops gradually beginning in mid-adulthood but can occur at any age.
Videoauswahl für Genetische ErkrankungenVideothek
Übersicht
Beschreibung
Sjögren's disease is a disorder whose main features are dry eyes and a dry mouth. The condition typically develops gradually beginning in mid-adulthood but can occur at any age.
Sjögren's disease is classified as an autoimmune disorder, one of a large group of conditions that occur when the immune system attacks the body's own tissues and organs. In Sjögren's disease, the immune system primarily attacks the glands that produce tears (the lacrimal glands) and saliva (the salivary glands), impairing the glands' ability to secrete these fluids.
Dry eyes may lead to itching, burning, a feeling of sand in the eyes, blurry vision, or intolerance of bright or fluorescent lighting. A dry mouth can feel chalky or full of cotton, and affected individuals may have difficulty speaking, tasting food, or swallowing. Because saliva helps protect the teeth and the tissues of the oral cavity, people with Sjögren's disease are at increased risk of tooth decay and infections in the mouth.
In most people with Sjögren's disease, dry eyes and dry mouth are the primary features of the disorder, and general health and life expectancy are largely unaffected. However, in some cases the immune system also attacks and damages other organs and tissues. This complication is known as extraglandular involvement. These individuals with Sjögren's disease may develop inflammation in connective tissues, which provide strength and flexibility to structures throughout the body. Disorders involving connective tissue inflammation are sometimes called rheumatic conditions. In Sjögren's disease, extraglandular involvement may result in painful inflammation of the joints and muscles; dry, itchy skin and skin rashes; chronic cough; a hoarse voice; kidney and liver problems; numbness or tingling in the hands and feet; and, in women, vaginal dryness. Prolonged and extreme tiredness (fatigue) severe enough to affect activities of daily living may also occur in this disorder. A small number of people with Sjögren's disease develop Lymphom, a blood-related cancer that causes tumour formation in the lymph nodes but can spread to other organs.
Some individuals who are first diagnosed with another rheumatic disorder, such as rheumatoide Arthritis oder systemischer Lupus erythematodes, later develop the dry eyes and dry mouth characteristic of Sjögren's disease. Other autoimmune disorders can also develop after the onset of Sjögren's disease. About half of all individuals with Sjögren's disease also have another autoimmune disorder.
Frequency
Sjögren's disease is a relatively common disorder; it occurs in 0.1 to 1 percent of the population. It is difficult to determine the exact prevalence because the characteristic features of this disorder, dry eyes and dry mouth, can also be caused by many other conditions. Women develop Sjögren's disease about 10 times more often than men; the specific reason for this difference is unknown but likely involves the effects of sex hormones on immune system function.
Ursachen
Sjögren's disease is thought to result from a combination of genetic and environmental factors; however, no associations between specific genetic changes and the development of Sjögren's disease have been confirmed. Researchers suspect that variations in many genes affect the risk of developing Sjögren's disease, but that development of the condition may be triggered by something in the environment. In particular, viral or bacterial infections, which activate the immune system, may have the potential to initiate the development of Sjögren's disease in susceptible individuals. The genetic variations that increase susceptibility may reduce the body's ability to turn off the immune response when it is no longer needed.
Vererbung
A predisposition to develop autoimmune disorders can be passed through generations in families. Relatives of people with Sjögren's disease are at an increased risk of developing autoimmune diseases, although they are not necessarily more likely to develop Sjögren's disease in particular. The inheritance pattern of this predisposition is unknown.
Other Names for This Condition
Dacryosialoadenopathia atrophicans
Gougerot-Houwer-Sjogren syndrome
Gougerot-Sjogren syndrome
Keratoconjunctivitis sicca
Keratoconjunctivitis sicca-xerostomia
Secreto-inhibitor-xerodermostenosis
Sicca syndrome
Sjogren disease
Sjogren syndrome
Sjogren's syndrome
Sjogren-Gougerot syndrome
Additional Information & Ressourcen
Patient Support and Advocacy Resources
Clinical Trials
Catalog of Genes and Diseases from OMIM
Scientific Articles on PubMed
Related patient information and medicines

Patient information leaflet
Sjögren-Syndrom
Sjögren's syndrome is an autoimmune disease that causes the glands that produce tears and saliva to stop working. It is a life-long condition but treatments can help control symptoms such as dry eyes and dry mouth. Key points Sjögren’s syndrome is an autoimm... Sjögren's syndrome is an autoimmune disease. It is caused by the body's immune system.

Patient information leaflet
Zöliakie
Down's syndrome. Autoimmune conditions such as autoimmune thyroid disease , primary biliary cholangitis Primary biliary cholangitis or Sjögren's syndrome Sjögren's syndrome. There are also other conditions that are linked with coeliac disease and may sometimes be caused by it. Apart from the complications listed above, people with coe... Sjögren's.

Patient information leaflet
Bewertung des kardiovaskulären Gesundheitsrisikos
A kardiovaskulären health risk assessment provides an accurate estimate of your risk of developing cardiovascular disease (eg, angina, heart attack, stroke or peripheral arterial disease) over the following 10 years, and provides an opportunity for you to make any changes that will reduce this risk. If you already have a cardiovascular disease or.

Patient information leaflet
Lebererkrankungen und Alkohol
Alkoholmissbrauch can lead to three main types of liver diseases: fatty liver , hepatitis and 'scarring' of the liver ( cirrhosis ). It can also lead to other health problems. What is alcoholic liver disease. Dr Sarah Jarvis MBE, GP and Clinical Director at Patient.info Drinking too viel Alkohol can lead to three main types of liver conditions: fatty.

Patient information leaflet
Menière-Krankheit
Menière-Krankheit typically causes attacks of dizziness with a spinning sensation (vertigo), hearing loss and noises in the ear (tinnitus). The attacks can vary in severity and in how often they occur. If you are a driver, you must stop driving if Ménière'... What is Ménière's disease. Ménière's disease is a condition of the inner ear. Ménière's.

Patient information leaflet
Zahnbelag und Zahnfleischerkrankungen
A build-up of plaque and tartar can lead to inflamed and infected gums. Mild gum disease is called gingivitis and is not usually serious. More severe gum disease (periodontitis), can lead to teeth falling out. This can usually prevent gum disease and treat mild-to-moderate gum disease. Specialist dental treatments may be needed for severe gum.
Weiterführende Lektüre und Referenzen
- Sjögren's disease; MedlinePlus, National Library of Medicine.
- Basiaga ML, Stern SM, Mehta JJ, Edens C, Randell RL, Pomorska A, Irga-Jaworska N, Ibarra MF, Bracaglia C, Nicolai R, Susic G, Boneparth A, Srinivasalu H, Dizon B, Kamdar AA, Goldberg B, Knupp-Oliveira S, Anton J, Mosquera JM, Appenzeller S, O'Neil KM, Protopapas SA, Saad-Magalhaes C, Akikusa JD, Thatayatikom A, Cha S, Nieto-Gonzalez JC, Lo MS, Treemarcki EB, Yokogawa N, Lieberman SM; Childhood Arthritis and Rheumatology Research Alliance and the International Childhood Sjogren Syndrome Workgroup. Childhood Sjogren syndrome: features of an international cohort and application of the 2016 ACR/EULAR classification criteria. Rheumatology (Oxford). 2021 Jul 1;60(7):3144-3155. doi: 10.1093/rheumatology/keaa757.
- Bayetto K, Logan RM. Sjogren's syndrome: a review of aetiology, pathogenesis, diagnosis and management. Aust Dent J. 2010 Jun;55 Suppl 1:39-47. doi: 10.1111/j.1834-7819.2010.01197.x.
- de Paiva CS, Pflugfelder SC. Mechanisms of Disease in Sjogren Syndrome-New Developments and Directions. Int J Mol Sci. 2020 Jan 19;21(2):650. doi: 10.3390/ijms21020650.
- de Paiva CS, Rocha EM. Sjogren syndrome: what and where are we looking for? Curr Opin Ophthalmol. 2015 Nov;26(6):517-25. doi: 10.1097/ICU.0000000000000208.
- Foulks GN, Forstot SL, Donshik PC, Forstot JZ, Goldstein MH, Lemp MA, Nelson JD, Nichols KK, Pflugfelder SC, Tanzer JM, Asbell P, Hammitt K, Jacobs DS. Clinical guidelines for management of dry eye associated with Sjogren disease. Ocul Surf. 2015 Apr;13(2):118-32. doi: 10.1016/j.jtos.2014.12.001. Epub 2015 Jan 15.
- Jonsson R, Vogelsang P, Volchenkov R, Espinosa A, Wahren-Herlenius M, Appel S. The complexity of Sjogren's syndrome: novel aspects on pathogenesis. Immunol Lett. 2011 Dec 30;141(1):1-9. doi: 10.1016/j.imlet.2011.06.007. Epub 2011 Jul 12.
- Jonsson R. Henrik Sjogren (1899-1986): the syndrome and his legacy. Ann Rheum Dis. 2021 Sep;80(9):1108-1109. doi: 10.1136/annrheumdis-2021-219942. Epub 2021 Jun 21. No abstract available.
- Mavragani CP, Moutsopoulos HM. Sjogren syndrome. CMAJ. 2014 Oct 21;186(15):E579-86. doi: 10.1503/cmaj.122037. Epub 2014 Feb 24. No abstract available.
- Peri Y, Agmon-Levin N, Theodor E, Shoenfeld Y. Sjogren's syndrome, the old and the new. Best Pract Res Clin Rheumatol. 2012 Feb;26(1):105-17. doi: 10.1016/j.berh.2012.01.012.
- Ramos-Casals M, Brito-Zeron P, Bombardieri S, Bootsma H, De Vita S, Dorner T, Fisher BA, Gottenberg JE, Hernandez-Molina G, Kocher A, Kostov B, Kruize AA, Mandl T, Ng WF, Retamozo S, Seror R, Shoenfeld Y, Siso-Almirall A, Tzioufas AG, Vitali C, Bowman S, Mariette X; EULAR-Sjogren Syndrome Task Force Group. EULAR recommendations for the management of Sjogren's syndrome with topical and systemic therapies. Ann Rheum Dis. 2020 Jan;79(1):3-18. doi: 10.1136/annrheumdis-2019-216114. Epub 2019 Oct 31.
Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.

